Levels of understanding...
Quote 1: "...and they can't
Levels of understanding...
Quote 1: "...and they can't try to persuade anyone here that ignores them."
- That shareholder doesn't seem to understand that he's the only one affected by ignoring others.
Quote 2: "Ignoring the bad guys does not make them go away."
- Slightly smarter shareholder, understands that sticking one's head in the sand doesn't completely make everything go away.
Quote 3: "The bashers can say whatever they want. Whatever they say won't affect JBI's operations and the stock price always eventually reflects the true fundamental value of the company."
- That's a trick quote--no shareholder I've seen on this board has attained that level of understanding yet.
Sorry to anyone who might be offended by this, but you need to understand that 'bashers' didn't drive JBI's share price down 98% from the high--that's a direct result of Mr. Bordynuik's claims of $10/bbl crude oil being fake and the slow realization dawning on investors. If any shareholders figure that out, they can at least stop averaging down in what they believe is the investment of the century. JBI is a penny stock which was founded on the basis of misleading investors about the capabilities of a secret catalyst--all too common in penny stocks.
Plastic2Oil, Inc. (PTOI) Stock Research Links
Yes, I understand your penny stock also is the real deal, created with the inventiveness of Edison and destined to be the next Microsoft. Yes, I understand that the delays are also only because your company is making their product and/or technology even more revolutionary.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue Reading
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
Top 5 Most Recently Viewed Articles
Caribou Biosciences Faces Legal Challenges Caribou Biosciences, Inc. (NASDAQ: CRBU) is currently embroiled in a class action lawsuit filed by investors who claim to have suffered significant losses due to alleged securities fraud. The lawsuit centers around actions that occurred between specific dates when investors were misled regarding key aspects of the company’s...
Continue Reading
HSBC Continental Europe's 2025 Interim Report Overview Recently, HSBC Continental Europe reported its financial results for the first half of 2025, showcasing significant strides in performance across various business segments. The Board of Directors approved the consolidated financial statements, marking a crucial step in the bank's strategic direction. Financial...
Continue Reading
AmpliTech Group Announces Major LOI for 5G Radios AmpliTech Group, Inc. is making headlines with a significant development in its operations. The company, known for its innovative signal processing components aimed at satellite communications and both public and private 5G networks, has entered into a letter of intent (LOI) to secure an impressive $78 million in purchase...
Continue Reading
Innovative Collaboration for Carbon Removal Elimini, a leading expert in carbon removal, has formed a strategic partnership with HOFOR to explore the development of a large-scale bioenergy with carbon capture and storage (BECCS) facility. This ambitious collaboration is aimed at transforming the existing power generation processes into a sustainable solution that helps...
Continue Reading
Newbury Street Acquisition Corp (NASDAQ: NBST) pulled the lever on a merger deadline extension back in 2024, giving itself an extra six months to close a potential business combination. This move wasn’t just some casual handwave; it came after a strong showing at a special meeting where shareholders cast 3,951,174 votes in favor of the extension—without a single...
Continue Reading